real-world efficacy of brentuximab vedotin as consolidation therapy in patients with hl
Published 1 year ago • 211 plays • Length 3:09Download video MP4
Download video MP3
Similar videos
-
3:24
results from the breselibet trial of brentuximab vedotin chemotherapy for r/r hodgkin lymphoma
-
1:11
brentuximab vedotin: current status and future considerations for this agent in hl treatment
-
1:04
updates on the use of brentuximab vedotin in later-stage hl
-
2:36
brentuximab vedotin versus pembrolizumab in r/r classical hodgkin lymphoma
-
1:08
nivolumab and brentuximab vedotin with or without bendamustine for r/r hodgkin lymphoma
-
1:27
treatment options for patients with hodgkin lymphoma who progress after brentuximab vedotin
-
3:07
current indications for the use of brentuximab vedotin in hodgkin lymphoma
-
8:50
brentuximab vedotin in treatment naïve chl patients: a 5-year update of the echelon-1 trial
-
3:02
real-world safety and efficacy of cilta-cel in r/r multiple myeloma
-
2:25
comparative effectiveness of epcoritamab versus real-world usual care in r/r follicular lymphoma
-
5:06
5-year follow-up of echelon-1: brentuximab plus avd versus abvd in hodgkin lymphoma
-
1:44
real-world outcomes of brexu-cel for r/r b-all: evidence from the cibmtr registry
-
0:45
difference between quality of life & patient-reported outcomes
-
7:09
the role of real-world evidence in the evaluation of new drugs
-
2:00
the real-world comparative effectiveness of covalent btkis in r/r mcl
-
2:15
promising advances in the field of ptcl: druggable mutations, brentuximab vedotin & l-asparaginase
-
2:22
real-world outcomes following dose reduction of first-line ibrutinib in patients with wm
-
2:00
real-world bortezomib prescribing patterns and outcomes in ndmm